Promising biological therapies for ulcerative colitis: A review of the literature
Nutritional modulators of ulcerative colitis: Clinical efficacies and mechanistic view
Mechanism of Action | Entyvio® (vedolizumab)
Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohn's Disease in the European Union | New Drug Approvals
Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview | BMC Medicine | Full Text
Cureus | Efficacy and Safety of Vedolizumab in Management of Moderate to Severe Ulcerative Colitis: A Systematic Review
New therapeutic avenues in ulcerative colitis: thinking out of the box | Gut
Biologics: Matching Drugs to Patients
Getting the Dose Right | Bio-Rad
Mica Duran Studio: Vedolizumab Method of Action – Artists' Blogs :: Medical Illustration Sourcebook
Ulcerative colitis: an update | RCP Journals
PDF] Vedolizumab for inflammatory bowel disease: From randomized controlled trials to real-life evidence | Semantic Scholar
Frontiers | Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases | Cell and Developmental Biology
Entyvio (vedolizumab) for the Treatment of Ulcerative Colitis and Crohn's Disease - Clinical Trials Arena
A mechanism of action of vedolizumab. | Download Scientific Diagram
A mechanism of action of vedolizumab. | Download Scientific Diagram
Vedolizumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Tofacitinib in ulcerative colitis | Immunotherapy
Efficacy of tofacitinib treatment in ulcerative colitis - ScienceDirect
Mechanism of vedolizumab. This image is modified from their original... | Download Scientific Diagram
Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology